Eli Lilly and Company — SEC Form 4 Filings
SEC Form 4 Data
Track insider buying and selling activity for Eli Lilly and Company (LLY). Data sourced from SEC EDGAR Form 4 filings and analyzed by StoxPulse AI for significance.
13
$130K total
7
$19.3M total
1.9x
Bullish Signal
20
Form 4 transactions
Buy − Sell value
Sale · Aug 17, 2026
Hernandez · Sale
Eli Lilly and Company insiders filed 20 Form 4 transactions in the period analyzed: 13 purchases totaling $130K and 7 sales totaling $19.3M. That puts the buy-to-sell ratio at 1.86, which we read as bullish on a directional basis.
The most active filer was Sulzberger Gabrielle with 3 transactions in this window. 18 of the 20 filings are flagged as routine — typically 10b5-1 scheduled trades rather than discretionary signals.
Form 4 filings are point-in-time disclosures and do not constitute investment advice. Routine sales under pre-arranged 10b5-1 plans should not be read as bearish.
| Insider | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Hernandez Edgardo | EVP & Pres., Mfg. Operations | Sale | 13 | $0.00 | $0.00 | 2026-09-02 |
| Dozier Eric | EVP, Chief People Officer | Sale | 216 | $0.00 | $0.00 | 2026-09-02 |
| Sulzberger Gabrielle | Director | Buy | 4.191 | $1183.16 | $5K | 2026-08-17 |
| LUCIANO JUAN R | Director | Buy | 13.453 | $1183.16 | $16K | 2026-08-17 |
| Fyrwald J Erik | Director | Buy | 8.382 | $1183.16 | $10K | 2026-08-17 |
| Alvarez Ralph | Director | Buy | 10.495 | $1183.16 | $12K | 2026-08-17 |
| Jonsson Patrik | EVP & President, LLY Int'l | Sale | 6,500 | $1175.10 | $7.6M | 2026-08-17 |
| Zakrowski Donald A | SVP, Finance, & CAO | Sale | 2,000 | $1185.01 | $2.4M | 2026-08-10 |
| Hakim Anat | EVP, GC & Secretary | Sale | 5,000 | $1190.00 | $6.0M | 2026-08-07 |
| Seymour Melissa | EVP, Global Quality | Buy | 981 | $0.00 | $0.00 | 2026-08-01 |
| Seymour Melissa | EVP, Global Quality | Sale | 438.707 | $1148.84 | $504K | 2026-08-01 |
| Sulzberger Gabrielle | Director | Buy | 4.323 | $1146.90 | $5K | 2026-07-20 |
| LUCIANO JUAN R | Director | Buy | 13.878 | $1146.90 | $16K | 2026-07-20 |
| Fyrwald J Erik | Director | Buy | 8.647 | $1146.90 | $10K | 2026-07-20 |
| Alvarez Ralph | Director | Buy | 10.826 | $1146.90 | $12K | 2026-07-20 |
| Sulzberger Gabrielle | Director | Buy | 4.39 | $1129.35 | $5K | 2026-06-15 |
| LUCIANO JUAN R | Director | Buy | 14.094 | $1129.35 | $16K | 2026-06-15 |
| Fyrwald J Erik | Director | Buy | 8.781 | $1129.35 | $10K | 2026-06-15 |
| Alvarez Ralph | Director | Buy | 10.995 | $1129.35 | $12K | 2026-06-15 |
| Yuffa Ilya | EVP&Pres, LLY USA&Global Capab | Sale | 2,500 | $1150.77 | $2.9M | 2026-06-10 |
Insider trading data for Eli Lilly and Company (LLY) is sourced directly from SEC Form 4 filings on the EDGAR database. Corporate insiders — including directors, officers, and shareholders owning more than 10% of the company — are legally required to report their transactions within two business days.
Insider purchases are often considered a bullish signal because executives are using their own money to buy shares, suggesting they believe the stock is undervalued. Insider sales, on the other hand, are more nuanced — they can reflect routine diversification plans (known as 10b5-1 plans), tax obligations, or genuine concerns about the company's outlook.
StoxPulse's AI system analyzes each LLY insider transaction to determine whether it appears routine or notable. We track the buy/sell ratio, total transaction values, and patterns over time to provide a clear picture of insider sentiment for Eli Lilly and Company.
AI earnings, financials, news & more
Translate any filing into plain English
Disclaimer: Insider trading data for Eli Lilly and Company (LLY) is sourced from SEC Form 4 filings and is provided for informational purposes only. Insider transactions should not be the sole basis for investment decisions. Always consult a qualified financial advisor.
Join the waitlist to receive instant AI notifications when Eli Lilly and Company insiders buy or sell shares.
Join the Waitlist